[Organization of a clinical information center on psychotropic drugs]

Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects.

Xenobiotica; the fate of foreign compounds in biological systems·2003

Sexual activity cardiological survey on members of the Israel Heart Society.

International journal of clinical practice·2003

[The function of Tenon's capsule revisited].

Journal francais d'ophtalmologie·2003

Development and validation of a bioanalytical method for the determination of the cholecystokinin type-1 (CCK(1)) receptor antagonist dexloxiglumide in human plasma.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2002

[Optimizing histological image data for 3-D reconstruction using an image equalizer].

Biomedizinische Technik. Biomedical engineering·2002

Nocardia pseudovaccinii sp. nov.

International journal of systematic and evolutionary microbiology·2002

Distinct pattern of reported adverse event with SGLT2 inhibitors in heart failure: A pharmacovigilance study using VigiBase data.

Therapie·2026

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

[Five years of ISO 9001 certification in pharmacotoxicology: Experience feedback and implementation modalities in vigilance structures].

Therapie·2026

Epidemiology and risk factors of severe cutaneous drug reactions and evaluation through available databases.

Therapie·2026

Characteristics of patients with opioid/benzodiazepine use disorder in a specialized consultation unit for prescription drug addiction: A cross-sectional study.

Therapie·2026

Anhedonia and neuropsychotropics: A pharmacovigilance-pharmacodynamic study.

Therapie·2026

Should we be monitoring patients on systemic dermatologic therapies for psychiatric adverse effects?: a proposed clinical framework.

The Journal of dermatological treatment·2026

Opioid Toxicity Associated With Tirzepatide in a Patient on Chronic Oral Morphine.

Cureus·2026

Observational characterization of self-reported SR-17018 exposure and outcomes in individuals with prior opioid use histories.

Frontiers in pharmacology·2026

Reconceptualizing Substance Use Disorders and Comorbidity: Moving Beyond Dual Diagnosis.

The Journal of nervous and mental disease·2026

Steered molecular dynamics and free-energy analysis of withanolide unbinding from tau kinases TTBK1 and GSK-3β.

Journal of biomolecular structure & dynamics·2026

Pain and Opioid Dose Reduction Based on Substance Use Disorder Status: Secondary Analysis from a Pragmatic Effectiveness Trial.

Journal of general internal medicine·2026

Related Experiment Videos

[Organization of a clinical information center on psychotropic drugs]

Related Concept Videos

Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects.

Sexual activity cardiological survey on members of the Israel Heart Society.

[The function of Tenon's capsule revisited].

Development and validation of a bioanalytical method for the determination of the cholecystokinin type-1 (CCK(1)) receptor antagonist dexloxiglumide in human plasma.

[Optimizing histological image data for 3-D reconstruction using an image equalizer].

Nocardia pseudovaccinii sp. nov.

Distinct pattern of reported adverse event with SGLT2 inhibitors in heart failure: A pharmacovigilance study using VigiBase data.

[Buprenorphine and pain management: Clinical insights and practical landmarks].

[Five years of ISO 9001 certification in pharmacotoxicology: Experience feedback and implementation modalities in vigilance structures].

Epidemiology and risk factors of severe cutaneous drug reactions and evaluation through available databases.

Characteristics of patients with opioid/benzodiazepine use disorder in a specialized consultation unit for prescription drug addiction: A cross-sectional study.

Anhedonia and neuropsychotropics: A pharmacovigilance-pharmacodynamic study.

Should we be monitoring patients on systemic dermatologic therapies for psychiatric adverse effects?: a proposed clinical framework.

Opioid Toxicity Associated With Tirzepatide in a Patient on Chronic Oral Morphine.

Observational characterization of self-reported SR-17018 exposure and outcomes in individuals with prior opioid use histories.

Reconceptualizing Substance Use Disorders and Comorbidity: Moving Beyond Dual Diagnosis.

Steered molecular dynamics and free-energy analysis of withanolide unbinding from tau kinases TTBK1 and GSK-3β.

Pain and Opioid Dose Reduction Based on Substance Use Disorder Status: Secondary Analysis from a Pragmatic Effectiveness Trial.

Related Experiment Videos

[Organization of a clinical information center on psychotropic drugs]

Related Concept Videos

Related Articles